The Motley Fool

Why I’d buy this FTSE 250 share to generate a second income in retirement

Image source: Getty Images.

Dunelm (LSE: DNLM) shares gained 12% Wednesday morning, and have now soared by 80% over the past 12 months. That brings two possibilities to mind. Are they going to keep on rising, or is this a growth share that’s set for a fall?

To put it into perspective a little, the share price is up 39% over five years, and it only started its recent climb at the end of 2018.

5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!

According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…

And if you click here we’ll show you something that could be key to unlocking 5G’s full potential...

Wednesday’s interim results were behind the latest uptick, with revenue up 6% over the first half last year. Pre-tax profit rose by 19.4% to £84.9m, and the firm lifted its interim dividend by 6.7%. Free cash flow is down 29%, but at £64.4m I don’t really see anything to worry about.

There’s net debt of £67.7m on the books (excluding IFRS 16 lease liabilities). But that’s of the same order of magnitude as six months of free cash flow, so no problem.


Where’s the growth coming from? Like so many retail businesses these days, online sales are making a significant contribution. The firm reported growth in tablet-based selling and click & collect (plus footfall too, so traditional shopping isn’t dead), saying the launch of its new digital platform is “enabling a new phase of growth for Dunelm.”

My big issue is valuation, with the shares on forward P/E multiples above 20. I think that’s too steep for a soft furnishings retailer — or almost any retailer.

I like Dunelm’s long-term income potential, but I see better buying opportunities ahead.


I mentioned on Monday that I’m keeping my eye on Primary Health Properties (LSE: PHP), whose shares are up 40% over the past 12 months. It’s another stock that I see as likely to provide steady long-term income, but also another that’s possibly on a bit of a heady growth valuation.

Analysts are bullish for the next couple of years, and I think 2019 results released Wednesday support that optimism.

Managing director Harry Hyman described the year as transformational, with the merger with MedicX the key event of the year. It was completed in March, and Hyman described it as “bringing together two high-quality and complementary portfolios in the UK and Ireland.” He added that it “provides a much stronger platform for the future and has already created significant value.


Net rental income for the year increased by 51%, with adjusted EPRS earnings up 62%. On a per-share basis for the merged company, EPS gained 5.8% and the dividend was lifted by 3.7%.

With an adjusted net asset value per share of 108p, the shares are currently priced at a premium of 51%. Is that too high? Well, I can only see demand for Primary Health’s healthcare real estate growing in the coming years. It’s also immune to factors that effect residential property, and is not at risk from retail pressure on the wider commercial sector.

We might see better buying opportunities in the medium term. But this is my pick of the two for long-term income with growth potential — and one to maybe top-up in any dips.

“This Stock Could Be Like Buying Amazon in 1997”

I'm sure you'll agree that's quite the statement from Motley Fool Co-Founder Tom Gardner.

But since our US analyst team first recommended shares in this unique tech stock back in 2016, the value has soared.

What's more, we firmly believe there's still plenty of upside in its future. In fact, even throughout the current coronavirus crisis, its performance has been beating Wall St expectations.

And right now, we're giving you a chance to discover exactly what has got our analysts all fired up about this niche industry phenomenon, in our FREE special report, A Top US Share From The Motley Fool.

Click here to claim your copy now — and we’ll tell you the name of this Top US Share… free of charge!

Alan Oscroft has no position in any of the shares mentioned. The Motley Fool UK has recommended Primary Health Properties. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

Where to invest £1,000 right now

Renowned stock-picker Mark Rogers and his select team of expert analysts at The Motley Fool UK have just revealed 6 "Best Buy" shares that they believe UK investors should consider buying NOW.

So if you’re looking for more top stock ideas to try and best position your portfolio in this market, then I have some good news for your today -- because we're offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our 'no quibbles' 30-day subscription fee refund guarantee.

Simply enter your email address below to discover how you can take advantage of this.

I would like to receive emails from you about product information and offers from The Fool and its business partners. Each of these emails will provide a link to unsubscribe from future emails. More information about how The Fool collects, stores, and handles personal data is available in its Privacy Statement.